Combination of cisplatin and radiation in cell culture: Effect of duration of exposure to drug and timing of irradiation
Open Access
- 9 February 1998
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 75 (4) , 635-642
Abstract
Responses to the combination of cisplatin (CDDP) and radiation in experimental and clinical studies have been reported to vary from high radiosensitization to clear sub-additivity. We examined the combined effect of CDDP with ionizing radiation in both murine mammary adenocarcinoma (EMT-6) and human ovarian carcinoma (OV-1063) cells with special reference to the duration of CDDP exposure and timing of irradiation. Cell survival was measured with a colorimetric assay of cell density. The nature of interaction of cisplatin and radiation was evaluated using isobolograms and a combination index (CI). Exposure of both cell lines to CDDP for 24 hr before irradiation yielded an additive or slightly sub-additive response only if the exposure was extended for a few more hours after irradiation. In EMT-6 cells, the combination of radiation with subsequent continuous as well as short-term (4 to 6 hr) CDDP treatment was found to have a clear sub-additive effect; dose escalation of each modality reduced the additional effect of the other. The sub-additive effect may be explained by a radiation-induced arrest of cells in late S phase, which was dose- and time-dependent. Post-radiation exposure to CDDP further increased the S-phase arrest. In contrast, a 2 hr post-radiation drug exposure resulted in a supra-additive combined effect. Our results stress the crucial role of the timing and the doses of both modalities as well as the duration of post-radiation drug exposure on their combined effect. Int. J. Cancer 75:635–642, 1998.Keywords
This publication has 27 references indexed in Scilit:
- Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymesCarcinogenesis, 1994
- De novo cisplatinum resistance does not influence cellular radiosensitivityEuropean Journal of Cancer, 1993
- The differential induction of collateral resistance to 62.5 MeV (p→Be+) neutrons and 4 MeV photons by exposure to cis-platinumInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993
- Noninvasive follow-up of platinum pharmacokinetics in the skin of patients on cisplatin chemotherapyCancer, 1993
- Effect of Acidic pH on Radiosensitization of FSallC Cells in Vitro by Misonidazole, Etanidazole, or cis-Diamminedichloroplatinum (II)Radiation Research, 1990
- The Independent Action of Radiation and Cisplatin on the Survival or Recovery of Human Normal or Tumour Cellsin Vitroorin VivoInternational Journal of Radiation Biology, 1989
- Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical dataInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1987
- Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neckCancer, 1984
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984
- Effect of cis-dichlorodiammine platinum IIand X rays on mammalian cell survivalInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1981